Armistice Capital’s Inhibikase Therapeutics IKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-626,500
| Closed | -$814K | – | 266 |
|
|
2024
Q3 | $814K | Buy |
626,500
+36,925
| +6% | +$48K | 0.01% | 173 |
|
|
2024
Q2 | $713K | Buy |
+589,575
| New | +$713K | 0.01% | 164 |
|
|
2023
Q4 | – | Sell |
-186,046
| Closed | -$259K | – | 325 |
|
|
2023
Q3 | $259K | Sell |
186,046
-310,501
| -63% | -$432K | ﹤0.01% | 185 |
|
|
2023
Q2 | $1.79M | Buy |
496,547
+3,054
| +0.6% | +$11K | 0.03% | 147 |
|
|
2023
Q1 | $1.95M | Buy |
+493,493
| New | +$1.95M | 0.03% | 124 |
|